NCT06584058View on ClinicalTrials.gov

HPP737 Substance Balance Study in Human

NANot yet recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 30, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

August 30, 2025

Conditions
Psoriasis
Interventions
DRUG

HPP737

\[14C\]HPP737 oral preparation, 20mg（150μCi）, once

Trial Locations (1)

215000

The Second Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

Newsoara Biopharma Co., Ltd.

INDUSTRY

NCT06584058 - HPP737 Substance Balance Study in Human | Biotech Hunter | Biotech Hunter